维普期刊资源整合服务平台（V6.5）

47篇 您的检索式：作者名="MOUL JW"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Long-term tolerability and efficacy of degarelix= 5-year results from a phase ]显示文摘	Crawford ED Shore ND Moul JW	2014	Urology2014，83，5：	1
2	Post-radical prostatectomy management options for positive surgical margins: argument for observation显示文摘	Moul JW	2009	Urol Oncol2009，27，1：	1
3	Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy显示文摘	MOUL JW WU H SUN L	2008	J Urol2008，179，5：	1
4	Hormonal therapy options for pros-tate-specific antigen-only recurrence of prostate cancer after previous local therapy显示文摘	Moul JW Zlotta AR		0，，03：	1
5	Surrogate end point for prostate cancer - specific mortalky after radical prostatectomy or radiation therapy显示文摘	D' Amico AV Moul JW Carroll PR	2003	J Natl Cancer Inst2003，95，18：	1
6	Prostate specific antigen recurrence after definitive therapy 显示文摘	Freedland S J Moul JW	2007	J Urol2007，177，6：	1
7	Proteomics in prostate cancer显示文摘	Banez LL Srivastava S Moul JW	2005	Curr Opin Urol2005，15，3：	1
8	Prostate specific antigen only progression of prostate cancer 显示文摘	Moul JW	2002	J Urol2002，163，6：	1
9	Immunohistochemical expression of p53 tumor suppressor gene protein in adult germ cell testis tumors : clinical correlation in stage Ⅰ disease显示文摘	Lewis DJ Sesterhenn IA Moul JW	1994	J Urol1994，152，8：	1
10	Prostate specific antigen recurrence after definitive therapy 显示文摘	Freedland SJ Moul JW	2007	J Urol2007，177，6：	1
11	Prostate specific antigen only progression of prostate cancer 显示文摘	Moul JW	2000	J Urol2000，163，6：	1
12	Prostate specific antigen values at the time of prostate cancer diagnosis in AfricanAmerican men 显示文摘	Moul JW Sesterhenn IA Connelly RR	1995	JAMA1995，274，：	1
13	Prostate-speeific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years 显示文摘	Sun L Moul JW Hotaling ]M	2007	BJU Int2007，99，4：	1
14	Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening显示文摘	Moul JW Sun L Hotaling JM	2007	J Urol2007，177，2：	1
15	Molecular markers in pros- tate cancer: the role in preoperative staging显示文摘	Moul JW Merseburger AS Srivastava S	2002	Clin Prostate Canc- er2002，1，1：	1
16	Twenty years of controversy surrounding combined an- drogen blockade for advanced prostate cancer显示文摘	Moul JW	2009	Cancer2009，115，15：	1
17	Managing advanced prostate cancer with Viadur (leuprolide acetate implant) 显示文摘	Moul JW Civitelli K	2001	Urol Nurs2001，21，6：	1
18	Combination of low-dose flutamide and finasteride for PSA-only recurrent prostate cancer after primary therapy显示文摘	Barqawi AB Moul JW Ziada A	2003	Urology2003，62，5：	1
19	Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy显示文摘	MOUL JW WU H SUN L	2004	J Urol2004，171，：	1
20	Risk factors for perineal seeding of prostate cancer after needle biopsy显示文摘	Moul JW Miles BJ Skoog SJ	1989	J Urol1989，142，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示